Potent inhibition of arterial smooth muscle tonic contractions by the selective myosin II inhibitor, blebbistatin

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 2, 2007, Pages 865-870

  Eddinger, Thomas J ^a   Meer, Daniel P ^b   Miner, Amy S ^c   Meehl, Joel ^a   Rovner, Arthur S ^d   Ratz, Paul H ^c  

^a Marquette University   (United States)

^b CARDINAL STRITCH UNIVERSITY   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ESCIN; BLEBBISTATIN; CALCIUM; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN II; MYOSIN IIA; MYOSIN LIGHT CHAIN; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DRUG BLOOD LEVEL; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; FEMORAL ARTERY; IC 50; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RENAL ARTERY;

ANIMALS; CHICKENS; FEMALE; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; MUSCLE, SMOOTH, VASCULAR; MYOSIN TYPE II; POTASSIUM CHLORIDE; RABBITS; VASOCONSTRICTION;

EID: 33846461305     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.109363     Document Type: Article

References (40)

1. Albrecht K, Schneider A, Liebetrau C, Ruegg JC, and Pfitzer G (1997) Exogenous caldesmon promotes relaxation of guinea-pig skinned taenia coli smooth muscles: inhibition of cooperative reattachment of latch bridges? Pflueg Arch Eur J Physiol 434:534-542.
2. Allingham JS, Smith R, and Rayment I (2005) The structural basis of blebbistatin inhibition and specificity for myosin II. Nat Struct Mol Biol 12:378-379.
3. Babu GJ, Warshaw DM, and Periasamy M (2000) Smooth muscle myosin heavy chain isoforms and their role in muscle physiology. Microsc Res Tech 50:532-540.
4. Butler TM, Mooers SU, and Siegman MJ (2006) Catch force links and the low to high force transition of myosin. Biophys J. 90:3193-3202.
5. Dillon PF, Aksoy MO, Driska SP, and Murphy RA (1981) Myosin phosphorylation and the cross-bridge cycle in arterial smooth muscle. Science (Wash DC) 211:495-497.
6. Eddinger TJ, Cassens RG, and Moss RL (1986) Mechanical and histochemical characterization of skeletal muscles from senescent rats. Am J Physiol 251:C421-C430.
7. Eddinger TJ and Murphy RA (1991) Developmental changes in actin and myosin heavy chain isoform expression in smooth muscle. Arch Biochem Biophys 284:232-237.
8. Eddinger TJ and Wolf JA (1993) Expression of four myosin heavy chain isoforms with development in mouse uterus. Cell Motil Cytoskelet 25:358-368.
9. 2+ sensitivity, and myosin light chain phosphorylation in urinary bladder smooth muscle of newborn mice. J Gen Physiol 125:187-196.
10. Gaylinn BD, Eddinger TJ, Martino PA, Monical PL, Hunt DF, and Murphy RA (1989) Expression of nonmuscle myosin heavy and light chains in smooth muscle. Am J Physiol 257:C997-C1004.
11. Giulian GG, Moss RL, and Greaser M (1983) Improved methodology for analysis and quantitation of proteins on one-dimensional silver-stained slab gels. Anal Biochem 129:277-287.
12. Haeberle JR (1994) Calponin decreases the rate of cross-bridge cycling and increases maximum force production by smooth muscle myosin in an in vitro motility assay. J Biol Chem 269:12424-12431.
13. Hai CM and Murphy RA (1988) Cross-bridge phosphorylation and regulation of latch state in smooth muscle. Am J Physiol 254:C99-C106.
14. Han SJ, Speich JE, Eddinger TJ, Berg KM, Miner AS, Call C, and Ratz PH (2006) Evidence for absence of latch-bridge formation in muscular saphenous arteries. Am J Physiol 291:H138-H146.
15. Hemric ME and Chalovich JM (1990) Characterization of caldesmon binding to myosin. J Biol Chem 265:19672-19678.
16. Herlihy JT and Murphy RA (1973) Length-tension relationship of smooth muscle of the hog carotid artery. Circ Res 33:257-283.
17. Ikebe M and Reardon S (1988) Binding of caldesmon to smooth muscle myosin. J Biol Chem 263:3055-3058.
18. Kamm KE and Stull JT (1985) The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25:593-620.
19. Khromov A, Somlyo AV, and Somlyo AP (1998) MgADP promotes a catch-like state developed through force-calcium hysteresis in tonic smooth muscle. Biophys J 75:1926-1934.
20. Kovacs M, Toth J, Hetenyi C, Malnasi-Csizmadia A, and Sellers JR (2004) Mechanism of blebbistatin inhibition of myosin II. J Biol Chem 279:35557-35563.
21. Limouze J, Straight AF, Mitchison T, and Sellers JR (2004) Specificity of blebbistatin, an inhibitor of myosin II. J Muscle Res Cell Motil 25:337-341.
22. Malmqvist U, Trybus KM, Yagi S, Carmichael J, and Fay FS (1997) Slow cycling of unphosphorylated myosin is inhibited by calponin, thus keeping smooth muscle relaxed. Proc Natl Acad Sci USA 94:7655-7660.
23. Morano I (2003) Tuning smooth muscle contraction by molecular motors. J Mol Med 81:481-487.
24. Obara K, Szymanski PT, Tao T, and Paul RJ (1996) Effects of calponin on isometric force and shortening velocity in permeabilized taenia coli smooth muscle. Am J Physiol 270:C481-C487.
25. Porter M, Evans MC, Miner AS, Berg KM, Ward KR, and Ratz PH (2006) Convergence of calcium desensitizing mechanisms activated by forskolin and phenylephrine pretreatment, but not 8-bromo-cGMP. Am J Physiol 290:C1552-C1559.
26. Rasmussen H, Takuwa Y, and Park S (1987) Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1:177-185.
27. 1-adrenergic receptor occupancy decreases relaxing potency of nifedipine by increasing myosin light chain phosphorylation. Circ Res 72:1308-1316.
28. Ratz PH (1995) Receptor activation induces short-term modulation of arterial contractions: memory in vascular smooth muscle. Am J Physiol 269:C417-C423.
29. Ratz PH, Hai C-M, and Murphy RA (1989) Dependence of stress on cross-bridge phosphorylation in vascular smooth muscle. Am J Physiol 256:C96-C100.
30. 2+ pools to activation of myosin phosphorylation and stress in swine carotid media. Circ Res 60:410-421.
31. Rhee AY, Ogut O, and Brozovich FV (2006) Nonmuscle myosin, force maintenance, and the tonic contractile phenotype in smooth muscle. Pflueg Arch Eur J Physiol 452:766-774.
32. Rovner AS, Freyzon Y, and Trybus KM (1997) An insert in the motor domain determines the functional properties of expressed smooth muscle myosin isoforms. J Muscle Res Cell Motil 18:103-110.
33. Shu S, Liu X, and Korn ED (2005) Blebbistatin and blebbistatin- inactivated myosin II inhibit myosin II-independent processes in Dictyostelium. Proc Natl Acad Sci USA 102:1472-1477.
34. Small JV (1995) Structure-function relationships in smooth muscle: the missing links. Bioessays 17:785-792.
35. Straight AF, Cheung A, Limouze J, Chen I, Westwood NJ, Sellers JR, and Mitchison TJ (2003) Dissecting temporal and spatial control of cytokinesis with a myosin II inhibitor. Science (Wash DC) 299:1743-1747.
36. Sutherland C and Walsh MP (1989) Phosphorylation of caldesmon prevents its interaction with smooth muscle myosin. J Biol Chem 264:578-583.
37. Szymanski PT (2004) Calponin (CaP) as a latch-bridge protein-a new concept in regulation of contractility in smooth muscles. J Muscle Res Cell Motil 25:7-19.
38. Szymanski PT and Tao T (1997) Localization of protein regions involved in the interaction between calponin and myosin. J Biol Chem 272:11142-11146.
39. Trybus KM (2000) Biochemical studies of myosin. Methods 22:327-335.
40. 2+ sensitization of arterial muscle. Am J Physiol 285:C1377-C1385.